title: Penicillium spp.: prolific producer for harnessing cytotoxic secondary metabolites.
abstract: Secondary metabolites from fungal endophytes have become an interesting, attractive, and alternative source for novel pharmaceuticals. Several novel compounds with diversified chemical structures have been isolated from endophytic fungi. The genus Penicillium has been exploited worldwide for its biosynthetic potential for producing highly versatile cytotoxic secondary metabolites. Many of the compounds isolated from various species of the genus Penicillium have shown promising in-vitro as well as in-vivo growth-inhibitory properties against different human cancers. Thus, in relation to this genus, Penicillium represents the most dependable source of cytotoxic compounds with potential applications as leads for anticancer drugs. This review outlines endophytic secondary metabolites from the genus Penicillium with a relevant role as cytotoxic agents.
authors.affiliation: aCancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, Jammu and Kashmir bAcademy of Scientific & Innovative Research (AcSIR), CSIR, New Delhi, India.
authors.forename: Mytre
authors.initials: M
authors.lastname: Koul
authors.forename: Shashank
authors.initials: S
authors.lastname: Singh
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology*; D006801:Humans; D010407:Penicillium / Q000737:chemistry* / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents